Religare, UPL, Maruti Suzuki, BLS International, Infosys, Wockhardt Are Buzzing On The Dealers' Desk
This edition of ‘Heard On The Street’ provides you with buzzing action on stocks like Religare, UPL, Maruti Suzuki, BLS International, Infosys, and Wockhardt.
NDTV Profit India has been tracking the action in the top dealing rooms of India’s financial capital, and this edition of ‘Heard On The Street’ provides you with buzzing action on stocks like Religare, UPL, Maruti Suzuki, BLS International, Infosys and Wockhardt.
Heard On The Street provides readers with what well-informed investors, especially HNIs, FIIs, DIIs, and mutual funds, are buying and selling in the stock market. It also tracks the latest unconfirmed/unverified chatter around stocks and/or sectors.
NDTV Profit picked up the following cues from the dealing room chatter during trade:
Religare
The company’s board will meet today to discuss fundraising. The buzz on the street is that the company might do a preferential issue to the Burman family of around Rs 1000 crore.
UPL
Dealers indicate that foreign institutional investors are showing buying interest at lower levels.
Maruti Suzuki
The stock is down in trade owing to the downgrade by UBS today. However, dealers indicate that there are buy flows on institutional desks at lower levels.
BLS International
Dealers indicate the high net worth individuals have been accumulating this counter in trade today on expectations of some positive development.
Infosys
Largely all IT stocks have declined in trade post weak numbers from TCS. But for Infosys, dealers indicate strong buying interest at lower levels.
Wockhardt
There are buy flows on large high-net-worth individual desks in anticipation of a good licensing deal post the Glenmark-AbbVie deal. As per dealers, even Wockhardt has a novel asset in phase III trials with best-in-class trial data.
Disclaimer: The mentioned stocks capture NDTV Profit's dealing room channel checks during trading hours. The information provided is for informational purposes. However, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, or suitability of the information. This content does not constitute financial, investment, or trading advice and should not be construed as a recommendation to buy, sell, or hold any securities.
